The UK Health Security Agency (UKHSA) has invited BAPM to join a guidance development group to revise the existing guidance for issuing HBIG for low weight babies under 1.5kg to women living with HepB. The rationale is to address concerns about delivering the recommended dose of HBIG to very low birth weight infants, which requires multiple IM injections.
The group will have three meetings, with the first planned for January 2025, and participants are asked to review evidence and guidance suggestions between meetings.
If you are a BAPM Member and interested in representing BAPM at this group, please contact the BAPM Office briefly outlining any previous experience or interest in this topic (max 150 words).
Deadline: Friday 17 January.
